Clinical trial
A Phase III Long-term Study of Ba253BINEB in Patients With COPD
NCT02182635 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Long-term Study of Ba253BINEB in Patients With COPD
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 1998
- Completion date
- Not reported
- Enrollment
- 74 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.